China
America's China Drug Habit: A $132 Billion Pipeline and a $6 Billion Peptide Boom
The FDA rejected a China-invented cancer drug on Sunday, just as Chinese molecules make up half of big pharma's major licensing deals. Our model puts peak sales of China-invented drugs at about $132 billion a year, and the US peptide market at about $6.3 billion.
Read article โ